BFRI Stock: The Hype Around Biofrontera Stock Explained
Biofrontera Inc (NASDAQ:BFRI) is a US based Bio-Technological subsidiary who develop treatments for dermatological conditions, in particular diseases caused primarily by exposure to sunlight. The German parent company, Biofrontera AG, chose to finance its US subsidiary via a IPO on the NASDAQ. The IPO was completed on 28 October 2021, raising $18 Million pricing each …
BFRI Stock: The Hype Around Biofrontera Stock Explained Read More »